RecruitingNot Applicable

Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances

United States1,000 participantsStarted 2016-01

Plain-language summary

This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.

Who can participate

Age range3 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Parent or legal guardian of individual with Smith-Magenis Syndrome Exclusion Criteria: * Not legal guardian of individual with SMS

What they're measuring

Number of individuals with Smith- Magenis syndrome

Timeframe: 5 years

Trial details

NCT IDNCT03154697

SponsorVanda Pharmaceuticals

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2030-12

Contact for this trial

Vanda Pharmaceuticals

202-734-3400 clinicaltrials@vandapharma.com

View on ClinicalTrials.gov More Sleep Disturbances in Smith-Magenis Syndrome trials